Anbio Biotechnology (NNNN) Accounts Payables (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Accounts Payables of $60.4 billion for Q2 2025, up 3713163.46% quarter-over-quarter from $1.6 million in Q4 2024.
Anbio Biotechnology (NNNN) Accounts Payables (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Accounts Payables for 3 consecutive years, with $60.4 billion the latest figure, recorded in Q2 2025.
- In Q2 2025, Accounts Payables changed N/A year-over-year to $60.4 billion; the TTM figure through Jun 2025 stood at $60.4 billion (changed N/A YoY), while the FY2024 annual figure was $1.6 million, up 96.49% from the prior year.
- Accounts Payables improved to $60.4 billion in Q2 2025 per NNNN's latest filing, from $1.6 million in the prior quarter.
- Across five years, Accounts Payables topped out at $60.4 billion in Q2 2025 and bottomed at $827151.0 in Q4 2023.
- Historically, Accounts Payables has averaged $20.1 billion across 3 years, with a median of $1.6 million in 2024.
- On a YoY basis, Accounts Payables climbed as much as 96.49% in 2024 and fell as far as 96.49% in 2024.
- Anbio Biotechnology's Accounts Payables stood at $827151.0 in 2023, then surged by 96.49% to $1.6 million in 2024, then surged by 3713163.46% to $60.4 billion in 2025.
- Business Quant data shows NNNN's Accounts Payables at $60.4 billion in Q2 2025, $1.6 million in Q4 2024, and $827151.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 277.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.11 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 968.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 308.92 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 1.04 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 252.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 701.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 233.30 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.03 Bn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 60.35 Bn |
| Dec 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 827,151.00 |